David William Ball
Direttore/Membro del Consiglio presso ALLERGY THERAPEUTICS PLC
Posizioni attive di David William Ball
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ALLERGY THERAPEUTICS PLC | Direttore/Membro del Consiglio | 27/06/2024 | - |
| Independent Dir/Board Member | 27/06/2024 | - | |
Argonaute RNA Ltd.
 Argonaute RNA Ltd. Miscellaneous Commercial ServicesCommercial Services Argonaute RNA Ltd. develops safe and reliable methods of temporarily silencing target genes in different tissue cells. The company is based in Bristol, UK. Michael Khan has been the CEO of the British company since 2021. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di David William Ball
Precedenti posizioni note di David William Ball
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Brainomix Ltd.
 Brainomix Ltd. BiotechnologyHealth Technology Brainomix Ltd. develops imaging biomarkers for neurological and cerebrovascular disorders. It offers e-ASPECTS, medical imaging software that automates a scoring system on brain images from acute ischaemic stroke patients to identify and quantify signs of early stroke damage and assist the physician's decision to treat. The company founded by Michalis Papadakis, Alastair Buchan, Iris Grunwald, Constantin Thiopoulos, and Michael Printzos in 2010 and is headquartered in Oxford, the United Kingdom. | Direttore/Membro del Consiglio | - | - |
Formazione di David William Ball
| University of Cambridge | Graduate Degree |
Statistiche
Distribuzione geografica
| Regno Unito | 5 |
Posizioni
| Director/Board Member | 4 |
| Independent Dir/Board Member | 1 |
| Graduate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ALLERGY THERAPEUTICS PLC | Health Technology |
| Aziende private | 2 |
|---|---|
Brainomix Ltd.
Brainomix Ltd. BiotechnologyHealth Technology Brainomix Ltd. develops imaging biomarkers for neurological and cerebrovascular disorders. It offers e-ASPECTS, medical imaging software that automates a scoring system on brain images from acute ischaemic stroke patients to identify and quantify signs of early stroke damage and assist the physician's decision to treat. The company founded by Michalis Papadakis, Alastair Buchan, Iris Grunwald, Constantin Thiopoulos, and Michael Printzos in 2010 and is headquartered in Oxford, the United Kingdom. | Health Technology |
Argonaute RNA Ltd.
Argonaute RNA Ltd. Miscellaneous Commercial ServicesCommercial Services Argonaute RNA Ltd. develops safe and reliable methods of temporarily silencing target genes in different tissue cells. The company is based in Bristol, UK. Michael Khan has been the CEO of the British company since 2021. | Commercial Services |
- Borsa valori
- Insiders
- David William Ball
- Esperienza
